Crossmark

Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies

Crossref DOI link: https://doi.org/10.15252/msb.20188664

Published Online: 2020-02-19

Published Print: 2020-02

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Eduati, Federica https://orcid.org/0000-0002-7822-3867
Jaaks, Patricia

Wappler, Jessica

Cramer, Thorsten https://orcid.org/0000-0002-6462-239X
Merten, Christoph A

Garnett, Mathew J

Saez‐Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Funding

Funding for this research was provided by:

Bayer
License Information

Version of Record valid from 2020-02-19
More Information

Publication History

Received: 2018-09-20

Accepted: 2020-01-28

Published: 2020-02-19